COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS
$1,234,505FY2025Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS · GrantIndex